INS and metabolic syndrome: The advantages and mechanism of PPAR-γ agonist includes inhibition of cytokine production by macrophages, reduction of oxidative stress, improving insulin resistance, control dyslipidemia due to the regulation of adipogenesis, and lowering blood pressure via vasodilation [22,24].